Cheng Chen

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza

P. Horby, Dayan Wang, F. Hayden, 2020, EBioMedicine.

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.

P. Horby, F. Hayden, Guohui Fan, 2019, The Journal of infectious diseases.

Symptomatic features and prognosis of 932 hospitalized patients with coronavirus disease 2019 in Wuhan

Bei-fang Ning, W. Xie, Ping-Fang Hu, 2021, Journal of Digestive Diseases.

Symptomatic Features of 932 Hospitalized Patients with COVID-19 in Wuhan

Bei-fang Ning, W. Xie, Ping-Fang Hu, 2021 .

Treatment of Covid-19 Patients With High Dose of Ulinastatin

Zhi-Min Liu, W. Xie, Hui Song, 2020 .

Clinical characteristics and prognosis of 1589 omicron patients with cardiovascular disease in Shanghai

Cheng Chen, Chun Yin, M. Jin, 2022, Journal of Infection.